clomiPRAMINE Hydrochloride, Capsules, USP, 75 mg recall — FDA D-0154-2026
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.